Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-07-31
Bourla Albert Files Pfizer (PFE) Form 4 - July 31, 2026
Bourla Albert bought 24 PFE shares worth $600.24 in this Form 4 filing, reported to the SEC on 2026-07-31.
- Insider
- Bourla Albert
- Issuer
- Pfizer Inc. PFE · NYSE
- Filed
- Period
- 2026-07-31
- Accession
- 0001225208-26-006900
- Source
- Official filing on sec.gov ↗
Transactions (1)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Bourla Albert | 2026-07-31 | Buy | 24 | $25.01 | $600.24 | Direct |
| Net change | +24 | +$600.24 | ||||
About Pfizer Inc.
Pfizer Inc. is a multinational pharmaceutical and biotechnology corporation, recognized for its role in the research, development, and manufacturing of healthcare products. Operating in the health sector, Pfizer focuses on creating innovative medicines and vaccines that significantly improve patients' lives. It is renowned for its contributions to pivotal health areas, such as oncology, immunology, cardiovascular health, and rare diseases. Pfizer maintains a robust pipeline of products at various stages of clinical development, enhancing its market position and impact. The company is instrumental in the global pharmaceutical landscape, contributing to public health with breakthroughs like vaccines and therapies that tackle some of the world's most challenging diseases. Headquartered in New York City, Pfizer plays a critical role in addressing urgent medical needs worldwide and is involved in extensive collaborations with scientific communities and healthcare systems. As a key player in the pharmaceutical industry, Pfizer’s developments and strategic initiatives can influence market trends and health policies, underscoring its importance in the global effort to combat health issues.
Track PFE insider activity
Get alerted when Pfizer Inc. executives buy or sell their shares.